Ga direct naar de content
  • Shop
    • Alles shoppen
    • Apparaten
      • CAROL Bike
      • Agen Band
      • Agen Robot
      • Apparaten vergelijken
    • Shop op doel
      • Heart
      • Mood & focus
      • Rest
      • Performance
      • Digestion
      • Skin & hair
      • Vitality
    • Bundels en abonnementen
      • Daily longevity bundle
      • Executive focus kit
      • Peak recovery stack
      • Lidmaatschap
  • App
  • Hoe het werkt
  • Wetenschap
  • Journal
  • Partners

Taal

  • Shop
    • Alles shoppen
    • Apparaten
    • Shop op doel
    • Bundels en abonnementen
  • App
  • Hoe het werkt
  • Wetenschap
  • Journal
  • Partners
  • Country/Region

      Geen resultaten gevonden
    • Afghanistan AFN ؋
    • Åland EUR €
    • Albanië ALL L
    • Algerije DZD د.ج
    • Andorra EUR €
    • Angola USD $
    • Anguilla XCD $
    • Antigua en Barbuda XCD $
    • Argentinië USD $
    • Armenië AMD դր.
    • Aruba AWG ƒ
    • Ascension SHP £
    • Australië AUD $
    • Azerbeidzjan AZN ₼
    • Bahama’s BSD $
    • Bahrein USD $
    • Bangladesh BDT ৳
    • Barbados BBD $
    • Belarus USD $
    • België EUR €
    • Belize BZD $
    • Benin XOF Fr
    • Bermuda USD $
    • Bhutan USD $
    • Bolivia BOB Bs.
    • Bosnië en Herzegovina BAM КМ
    • Botswana BWP P
    • Brazilië USD $
    • Brits Indische Oceaanterritorium USD $
    • Britse Maagdeneilanden USD $
    • Brunei BND $
    • Bulgarije EUR €
    • Burkina Faso XOF Fr
    • Burundi BIF Fr
    • Cambodja KHR ៛
    • Canada CAD $
    • Caribisch Nederland USD $
    • Centraal-Afrikaanse Republiek XAF CFA
    • Chili USD $
    • China CNY ¥
    • Christmaseiland AUD $
    • Cocoseilanden AUD $
    • Colombia USD $
    • Comoren KMF Fr
    • Congo-Brazzaville XAF CFA
    • Congo-Kinshasa CDF Fr
    • Cookeilanden NZD $
    • Costa Rica CRC ₡
    • Curaçao ANG ƒ
    • Cyprus EUR €
    • Denemarken DKK kr.
    • Djibouti DJF Fdj
    • Dominica XCD $
    • Dominicaanse Republiek DOP $
    • Duitsland EUR €
    • Ecuador USD $
    • Egypte EGP ج.م
    • El Salvador USD $
    • Equatoriaal-Guinea XAF CFA
    • Eritrea USD $
    • Estland EUR €
    • Eswatini USD $
    • Ethiopië ETB Br
    • Faeröer DKK kr.
    • Falklandeilanden FKP £
    • Fiji FJD $
    • Filipijnen PHP ₱
    • Finland EUR €
    • Frankrijk EUR €
    • Frans-Guyana EUR €
    • Frans-Polynesië XPF Fr
    • Franse Gebieden in de zuidelijke Indische Oceaan EUR €
    • Gabon XOF Fr
    • Gambia GMD D
    • Georgië USD $
    • Ghana USD $
    • Gibraltar GBP £
    • Grenada XCD $
    • Griekenland EUR €
    • Groenland DKK kr.
    • Guadeloupe EUR €
    • Guatemala GTQ Q
    • Guernsey GBP £
    • Guinee GNF Fr
    • Guinee-Bissau XOF Fr
    • Guyana GYD $
    • Haïti USD $
    • Honduras HNL L
    • Hongarije HUF Ft
    • Hongkong SAR van China HKD $
    • IJsland ISK kr
    • Ierland EUR €
    • India INR ₹
    • Indonesië IDR Rp
    • Irak USD $
    • Isle of Man GBP £
    • Israël ILS ₪
    • Italië EUR €
    • Ivoorkust XOF Fr
    • Jamaica JMD $
    • Japan JPY ¥
    • Jemen YER ﷼
    • Jersey USD $
    • Jordanië USD $
    • Kaaimaneilanden KYD $
    • Kaapverdië CVE $
    • Kameroen XAF CFA
    • Kazachstan KZT ₸
    • Kenia KES KSh
    • Kirgizië KGS som
    • Kiribati USD $
    • Kleine afgelegen eilanden van de Verenigde Staten USD $
    • Koeweit USD $
    • Kosovo EUR €
    • Kroatië EUR €
    • Laos LAK ₭
    • Lesotho USD $
    • Letland EUR €
    • Libanon LBP ل.ل
    • Liberia USD $
    • Libië USD $
    • Liechtenstein CHF CHF
    • Litouwen EUR €
    • Luxemburg EUR €
    • Macau SAR van China MOP P
    • Madagaskar USD $
    • Malawi MWK MK
    • Maldiven MVR MVR
    • Maleisië MYR RM
    • Mali XOF Fr
    • Malta EUR €
    • Marokko MAD د.م.
    • Martinique EUR €
    • Mauritanië USD $
    • Mauritius MUR ₨
    • Mayotte EUR €
    • Mexico USD $
    • Moldavië MDL L
    • Monaco EUR €
    • Mongolië MNT ₮
    • Montenegro EUR €
    • Montserrat XCD $
    • Mozambique USD $
    • Myanmar (Birma) MMK K
    • Namibië USD $
    • Nauru AUD $
    • Nederland EUR €
    • Nepal NPR Rs.
    • Nicaragua NIO C$
    • Nieuw-Caledonië XPF Fr
    • Nieuw-Zeeland NZD $
    • Niger XOF Fr
    • Nigeria NGN ₦
    • Niue NZD $
    • Noord-Macedonië MKD ден
    • Noorwegen USD $
    • Norfolk AUD $
    • Oeganda UGX USh
    • Oekraïne UAH ₴
    • Oezbekistan UZS so'm
    • Oman USD $
    • Oost-Timor USD $
    • Oostenrijk EUR €
    • Pakistan PKR ₨
    • Palestijnse gebieden ILS ₪
    • Panama USD $
    • Papoea-Nieuw-Guinea PGK K
    • Paraguay PYG ₲
    • Peru PEN S/
    • Pitcairneilanden NZD $
    • Polen PLN zł
    • Portugal EUR €
    • Qatar QAR ر.ق
    • Réunion EUR €
    • Roemenië RON Lei
    • Rusland USD $
    • Rwanda RWF FRw
    • Saint Kitts en Nevis XCD $
    • Saint Lucia XCD $
    • Saint Vincent en de Grenadines XCD $
    • Saint-Barthélemy EUR €
    • Saint-Martin EUR €
    • Saint-Pierre en Miquelon EUR €
    • Salomonseilanden SBD $
    • Samoa WST T
    • San Marino EUR €
    • Sao Tomé en Principe STD Db
    • Saoedi-Arabië SAR ر.س
    • Senegal XOF Fr
    • Servië RSD РСД
    • Seychellen USD $
    • Sierra Leone SLL Le
    • Singapore SGD $
    • Sint-Helena SHP £
    • Sint-Maarten ANG ƒ
    • Slovenië EUR €
    • Slowakije EUR €
    • Soedan USD $
    • Somalië USD $
    • Spanje EUR €
    • Spitsbergen en Jan Mayen USD $
    • Sri Lanka LKR ₨
    • Suriname USD $
    • Tadzjikistan TJS ЅМ
    • Taiwan TWD $
    • Tanzania TZS Sh
    • Thailand THB ฿
    • Togo XOF Fr
    • Tokelau NZD $
    • Tonga TOP T$
    • Trinidad en Tobago TTD $
    • Tristan da Cunha GBP £
    • Tsjaad XAF CFA
    • Tsjechië CZK Kč
    • Tunesië USD $
    • Turkije USD $
    • Turkmenistan USD $
    • Turks- en Caicoseilanden USD $
    • Tuvalu AUD $
    • Uruguay UYU $U
    • Vanuatu VUV Vt
    • Vaticaanstad EUR €
    • Venezuela USD $
    • Verenigd Koninkrijk GBP £
    • Verenigde Arabische Emiraten AED د.إ
    • Verenigde Staten USD $
    • Vietnam VND ₫
    • Wallis en Futuna XPF Fr
    • Westelijke Sahara MAD د.م.
    • Zambia USD $
    • Zimbabwe USD $
    • Zuid-Afrika USD $
    • Zuid-Georgia en Zuidelijke Sandwicheilanden GBP £
    • Zuid-Korea KRW ₩
    • Zuid-Soedan USD $
    • Zweden SEK kr
    • Zwitserland CHF CHF

    Taal

    Taal
    Account

    Je winkelwagen is leeg

    Heb je een account? Log in om sneller af te rekenen.

    Doorgaan met winkelen

    ← Gidsen over longevity & supplementen

    Muscle Power Leaves Before Strength Does

    LongevityTraining10 min leestijd Aug 9, 2026Bijgewerkt Aug 10, 2026

    Share

    Two diverging curves showing muscle power declining faster than force with age

    In deze gids

      Share

      There is a dynamometer in your kitchen, and you have been sitting in it for years.

      The test is unglamorous enough to be insulting. Sit in an ordinary chair, cross your arms over your chest, and stand up and sit down as many times as you can in thirty seconds. No equipment, no lab, no subscription. Researchers in Toledo, Spain have been running a version of this on thousands of older adults, and when they turned the repetition counts into watts and looked at what happened to people afterwards, the chair turned out to know things.

      What interests me is not that the test predicts something. Plenty of cheap tests do. It is that the quantity it measures — power — is the one the fitness culture almost never talks about, while the quantity we all talk about, strength, is the one that holds up longest.

      An older woman rising from a wooden chair with her arms folded across her chest, in morning light
      Arms crossed, feet flat, up and down for thirty seconds. The protocol is this ordinary.

      Power falls at roughly twice the rate of force

      Muscle strength is how much force you can produce. Muscle power is force multiplied by the speed you produce it at — the physics of catching yourself on a stair, not the physics of a heavy shrug. They sound like the same virtue described twice. They age completely differently.

      A Belgian group followed 489 adults for a decade, testing knee extension at baseline and again ten years later, and separated the force component from the velocity component instead of collapsing both into one score. In the older adults, maximum power fell by about 2.2–2.4% per year. Force, in the same people, fell by about 1.09–1.27%. Power was draining out at roughly double the rate of the thing most of us train.

      The composition of the loss also shifted. In middle age, the early dent in power came mostly from force. Later, velocity joined in — a progressively blunted ability to produce force quickly. Which means two people can post the same one-rep max and be in genuinely different condition, because one of them can still express it in under a second and the other cannot.

      Ten-year longitudinal decline

      Annual loss in muscle power vs force, by age group (% per year)

      Youngpower −0.6%/yr
      Middle-agedforce −0.65 to −1.02%/yr
      Middle-agedpower −1.1 to −1.4%/yr
      Olderforce −1.09 to −1.27%/yr
      Olderpower −2.2 to −2.4%/yr
      Maximum powerForce

      Knee-extension data from Alcazar et al., Journal of Cachexia, Sarcopenia and Muscle 2023 (n = 489, tested 2002–2004 and again 2012–2015). Every reported figure is printed in its label; where the paper gives a range, the bar width uses the midpoint of that range. Knee extension only — one joint, not the whole body.

      Why the grip test misses it

      We have written admiringly about grip strength, and I still think it earns its place as a five-second proxy for how the whole body is holding up. But it is worth reporting the study that argues against us.

      Researchers looked at older adults around the age of ninety and asked which measurement best explained who was still physically independent. They put sit-to-stand power, handgrip strength, physical activity and sedentary time into the same model. Sit-to-stand power carried a standardised coefficient of 0.45. Handgrip came in at −0.02 — statistically indistinguishable from contributing nothing once power was in the room. Sedentary time (−0.28) mattered more than grip did.

      That is a cross-sectional analysis in a cohort near ninety, so it describes a snapshot rather than a sequence, and grip may well be measuring something different and still useful earlier in life. But the direction is uncomfortable and worth sitting with: a squeeze is a slow, isometric act. It samples force with the velocity term set to zero. It is, almost by design, blind to the thing that erodes first.

      What low power travels with — in three honest tiers

      The evidence here is real but stacked, and the tiers are not equally strong. Worth separating them rather than quoting the scariest number.

      Cross-sectional, so the largest numbers. Working from 1,475 adults aged 65–98 in Toledo, researchers derived cut-offs for low relative sit-to-stand power: below 2.53 W/kg for men, below 2.01 W/kg for women. People under those lines were more likely to be frail (odds ratio 4.4 in men, 5.2 in women) and to have slow habitual gait speed (3.4 and 6.1). Large odds — but measured at the same moment, so they cannot tell you which came first.

      Prospective, so smaller and more believable. Following 839 of the same adults for about five years, low power was associated with later development of frailty (OR 2.51), difficulty with basic daily activities (1.70), difficulty with instrumental ones (1.79), and increased medication use (1.51). Note what did not reach significance: cognitive impairment (1.38), depression (1.29), and frailty measured by a second definition. The signal is about physical function specifically. It is not a general index of everything.

      Mortality. In the 1,876-person analysis, men below the power threshold had a 57% higher risk of death from any cause and women more than double the risk over roughly nine years. Falls and fractures also clustered below the line — but those were history, recorded at the same visit as the test, which is a different and weaker kind of finding than the prospective ones. More than half the cohort sat below the cut-off for their sex.

      All of it is association. The most obvious rival explanation is that early illness makes people slower out of a chair, rather than slowness making them ill, and no observational study of this design can rule that out. The five-year study also lost its frailer participants to attrition, which biases toward the healthy. Read these numbers as a signal about the body's current condition, not as a forecast.

      The velocity term is trainable, which is the whole point

      A risk marker you can't move is trivia. This one moves.

      A meta-analysis pooled fourteen trials of high-speed resistance training in independent older adults aged 69–82 — 408 participants randomised. The protocols were remarkably consistent: loads of 40–80% of one-rep max, the lifting phase performed as fast as possible (under a second), the lowering phase controlled over two to three seconds, three sessions a week for eight to sixteen weeks. Pooled effect on neuromuscular function was moderate (SMD 0.70, 95% CI 0.24–1.15); on physical function, 0.55. The authors concluded that ten weeks or more, three times a week, is where the reliable gains showed up.

      Honesty about that evidence: twelve of the fourteen studies were rated low methodological quality, only one was pre-registered, the samples were small, heterogeneity was moderate to substantial, and nobody followed participants long enough to know whether the gains stick. This is a promising and coherent literature, not a settled one.

      Intent is what you change, not the weight

      Here is the part that surprised me when I first understood it, and the part worth taking into this week's training.

      Power training is not a different exercise list. It is the same squat, press and row performed with a different intention: move the load fast on the way up, control it on the way down. The load itself sits in a moderate range — 40–80% of your maximum, not the grinding heavy end, because you cannot accelerate something you can barely lift. If your gym time is a slow, controlled, respectable grind through every repetition, you are training force and leaving velocity untouched.

      The everyday version needs no gym at all. Stand up out of the chair fast; sit back down slowly. Take the stairs two at a time where it is safe. Carry the shopping and set it down deliberately. These sound like nothing, and they are structurally the same instruction the trials gave: brief, deliberate, fast concentric effort, repeated often enough to matter.

      One caution the enthusiasm tends to skip. Fast movement is a skill before it is a stimulus, and connective tissue adapts on a slower clock than muscle does. If you are coming back from a long gap, add speed gradually and to movements you already own, and if you have joint problems, a balance issue, or any cardiac history, get advice from a clinician before you start accelerating loads.

      Practical

      Testing yourself, and what the chair cannot tell you

      How to run the 30-second version
      A firm chair of ordinary height, no arms used. Cross your arms over your chest, feet flat. Stand fully upright and sit fully back down, as many times as you can in thirty seconds. Same chair, same shoes, same time of day whenever you repeat it — the comparison is only worth as much as its consistency. If you feel unsteady, do it with a wall or a second person beside you, or skip it.
      Why we suggest counting reps, not watts
      The published thresholds (2.53 W/kg for men, 2.01 for women) come from an equation that converts body mass, height and repetition count into watts per kilogram — and they were derived in adults aged 65–98. They are not a benchmark for a 45-year-old, and a number you compute at home is not a clinical result. Your own repetition count, under fixed conditions, retested every few months, is the honest instrument.
      What would make this a doctor's question
      A clear drop in what you can do rather than a slow drift, new unsteadiness or a fall, dizziness on standing, or breathlessness and chest discomfort during ordinary effort. No test you run at home diagnoses anything, and this one is no exception — it describes today's function, nothing more.

      Method follows the 30-second sit-to-stand protocol used in the Toledo Study for Healthy Aging; thresholds from Garcia-Aguirre et al. 2025. Educational information, not medical advice.

      Measure the trend, not the digit

      The reason this test appeals to me is the same reason we keep arguing that a sensor is only as good as the question you ask it. A repetition count is crude. It is also yours, repeatable, free, and sensitive to something that is genuinely changing underneath.

      Do it once and you have a number of no particular meaning. Do it in February, May and September under the same conditions and you have a trend line for a physical capacity that most people never look at until it announces itself in a stumble. That is the same logic behind reading your resting heart rate and HRV as drift against your own baseline rather than against a population chart, and behind treating a longevity protocol as a loop — measure, act, re-measure — instead of a list.

      Use numbers to correct fantasy, not to replace experience. The fantasy here is that strength is the whole story and that a respectable deadlift means the machinery is intact. The experience is standing up from a low sofa and noticing, for the first time, that you thought about it first.

      The bottom line

      Power — force expressed quickly — declines about twice as fast as force does, starts earlier than most people assume, and appears to track physical independence better than the grip test we all reach for. Low sit-to-stand power is associated with frailty, functional difficulty and higher mortality in adults over 65, though the evidence is observational and the opposite explanation cannot be excluded. The trainable variable is not the weight but the intent: moderate loads moved fast on the way up, controlled on the way down, three times a week, judged over months. Test yourself in a chair a few times a year, and read the direction rather than the digit. If you are tracking training load and recovery alongside it, the Agen Band and the physical performance range are there for the parts a chair can't see — but the chair remains the cheapest honest instrument in the house.

      Bronnen

      1. Alcazar J, Rodriguez-Lopez C, Delecluse C, Thomis M, Van Roie E. Ten-year longitudinal changes in muscle power, force, and velocity in young, middle-aged, and older adults. Journal of Cachexia, Sarcopenia and Muscle 2023;14(2):1019-1032. https://doi.org/10.1002/jcsm.13184
      2. Hetherington-Rauth M, Magalhaes JP, Alcazar J, et al. Relative Sit-to-Stand Muscle Power Predicts an Older Adult's Physical Independence at Age of 90 Yrs Beyond That of Relative Handgrip Strength, Physical Activity, and Sedentary Time. American Journal of Physical Medicine & Rehabilitation 2022;101(11):995-1000. https://doi.org/10.1097/PHM.0000000000001945
      3. Garcia-Aguirre M, et al. Cut-Off Points for Low Relative 30-s Sit-to-Stand Power and Their Associations With Adverse Health Conditions. Journal of Cachexia, Sarcopenia and Muscle 2025;16(1):e13676. https://doi.org/10.1002/jcsm.13676
      4. Garcia-Aguirre M, Baltasar-Fernandez I, Alcazar J, et al. Low Relative Sit-to-Stand Power Is Associated With the Development of Adverse Health Outcomes: A 5-Year Longitudinal Study. Journal of Cachexia, Sarcopenia and Muscle 2025;16(3):e13852. https://doi.org/10.1002/jcsm.13852
      5. Low relative sit-to-stand power is associated with history of falls and fractures, prospective hospitalization, and all-cause mortality in older adults from the Toledo Study for Healthy Aging. Journal of Sport and Health Science 2026;15. https://doi.org/10.1016/j.jshs.2025.101080
      6. Martins AD, Fernandes O, Pereira A, et al. The Effects of High-Speed Resistance Training on Health Outcomes in Independent Older Adults: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 2022;19(9):5390. https://doi.org/10.3390/ijerph19095390

      Over de auteur

      Vladimir Sitnikov is the founder of Agen. He writes about longevity, measurement, and building a wellbeing system that adapts to you.

      Dit artikel is uitsluitend bedoeld voor educatieve doeleinden en is geen medisch advies. Deze uitspraken zijn niet beoordeeld door de Food and Drug Administration. Producten van Agen zijn niet bedoeld om een ziekte te diagnosticeren, behandelen, genezen of voorkomen. Raadpleeg je arts voordat je met een supplement begint, zeker als je zwanger bent, borstvoeding geeft of medicijnen gebruikt.

      Verder lezen

      Vitamine D en buikvet: de kop zette de pijl de verkeerde kant op Longevity · 11 min leestijd Zes trappen per dag: wat het trappenonderzoek werkelijk mat Training · 9 min leestijd Zorgt zingeving er echt voor dat je langer leeft? Longevity · 11 min leestijd

      Houd je protocol eerlijk.

      Elk Agen-supplement wordt op bewijs gescoord, op dezelfde manier als deze gidsen zijn geschreven. Zie wat de wetenschap ondersteunt.

      Shop supplementen
      Agen Com Pte Ltd

      Houd de regie over je gezondheid en ondersteun je welzijn op de lange termijn door supplementen, slimme apparaten en AI-begeleiding te verenigen in één systeem.

      Navigeer

      • App
      • Robot
      • Band
      • CAROL Bike
      • Supplementen
      • FAQ
      • Journal
      • Vacatures
      • Trust center
      • Contact

      Informatie

      • Privacybeleid
      • Servicevoorwaarden
      • Verzendbeleid
      • Retour en terugbetaling
      • Betaalbeleid
      • Garantiebeleid

      Contact

      Agen Com Pte. Ltd.

      8 Temasek Boulevard #30-01/02 Suntec Tower 3, Singapore 038988

      UEN: 202421957H

      info@agen.com

      +65 8422 1101

      Deze uitspraken zijn niet beoordeeld door de Food and Drug Administration. Dit product is niet bedoeld om ziekten te diagnosticeren, behandelen, genezen of voorkomen. Zoals bij elk voedingssupplement dient u het gebruik van dit product met uw zorgverlener te bespreken.

      Betaalmethoden
      • American Express
      • Apple Pay
      • Google Pay
      • Mastercard
      • Shop Pay
      • Union Pay
      • Visa

      Copyright © 2026 Agen Com Pte. Ltd.

      Zoekopdracht

      Producten

      • Agen Band
        Agen Band biomarker wearable, front view Agen Band biomarker wearable — supplement facts and ingredients

        Agen Band

        Normale prijs  $149.00 Prijs met korting  $99.00
      • Agen Robot & Starterpakket
        Agen Robot supplement dispenser on a kitchen counter Agen Robot supplement dispenser — supplement facts and ingredients

        Agen Robot & Starterpakket

        $399.00
      • Ashwagandha
        Agen Ashwagandha supplement, front of bottle Agen Ashwagandha bottle on a travertine counter in soft morning light

        Ashwagandha

        $15.00
      • Astaxanthine
        Agen Astaxanthin supplement, front of bottle

        Astaxanthine

        $6.00

      Je bent erbij.

      Je 10%-code staat hieronder — en is ook onderweg naar je inbox.

      READY10
      Gratis verzending vanaf $ 100 — $ 150 internationaal

      10% op je eerste bestelling

      Supplementen gedoseerd voor jouw lichaam — niet voor het gemiddelde. Gratis verzending vanaf $ 100 — $ 150 internationaal.

      Directe code · Geen spam · Altijd uitschrijfbaar

      Door je aan te melden ga je akkoord met marketingmails. Zie ons privacybeleid en voorwaarden.